0001071840 2025-09-01 2026-05-31 0001071840 2026-07-10 0001071840 2026-05-31 0001071840 2025-08-31 0001071840 2026-03-01 2026-05-31 0001071840 2025-03-01 2025-05-31 0001071840 2024-09-01 2025-05-31 0001071840 us-gaap:CommonStockMember 2025-08-31 0001071840 us-gaap:AdditionalPaidInCapitalMember 2025-08-31 0001071840 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-08-31 0001071840 us-gaap:RetainedEarningsMember 2025-08-31 0001071840 us-gaap:CommonStockMember 2025-11-30 0001071840 us-gaap:AdditionalPaidInCapitalMember 2025-11-30 0001071840 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-11-30 0001071840 us-gaap:RetainedEarningsMember 2025-11-30 0001071840 2025-11-30 0001071840 us-gaap:CommonStockMember 2026-02-28 0001071840 us-gaap:AdditionalPaidInCapitalMember 2026-02-28 0001071840 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-02-28 0001071840 us-gaap:RetainedEarningsMember 2026-02-28 0001071840 2026-02-28 0001071840 us-gaap:CommonStockMember 2024-08-31 0001071840 us-gaap:AdditionalPaidInCapitalMember 2024-08-31 0001071840 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-08-31 0001071840 us-gaap:RetainedEarningsMember 2024-08-31 0001071840 2024-08-31 0001071840 us-gaap:CommonStockMember 2024-11-30 0001071840 us-gaap:AdditionalPaidInCapitalMember 2024-11-30 0001071840 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-11-30 0001071840 us-gaap:RetainedEarningsMember 2024-11-30 0001071840 2024-11-30 0001071840 us-gaap:CommonStockMember 2025-02-28 0001071840 us-gaap:AdditionalPaidInCapitalMember 2025-02-28 0001071840 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-02-28 0001071840 us-gaap:RetainedEarningsMember 2025-02-28 0001071840 2025-02-28 0001071840 us-gaap:CommonStockMember 2025-09-01 2025-11-30 0001071840 us-gaap:AdditionalPaidInCapitalMember 2025-09-01 2025-11-30 0001071840 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-09-01 2025-11-30 0001071840 us-gaap:RetainedEarningsMember 2025-09-01 2025-11-30 0001071840 2025-09-01 2025-11-30 0001071840 us-gaap:CommonStockMember 2025-12-01 2026-02-28 0001071840 us-gaap:AdditionalPaidInCapitalMember 2025-12-01 2026-02-28 0001071840 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-12-01 2026-02-28 0001071840 us-gaap:RetainedEarningsMember 2025-12-01 2026-02-28 0001071840 2025-12-01 2026-02-28 0001071840 us-gaap:CommonStockMember 2026-03-01 2026-05-31 0001071840 us-gaap:AdditionalPaidInCapitalMember 2026-03-01 2026-05-31 0001071840 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-03-01 2026-05-31 0001071840 us-gaap:RetainedEarningsMember 2026-03-01 2026-05-31 0001071840 us-gaap:CommonStockMember 2024-09-01 2024-11-30 0001071840 us-gaap:AdditionalPaidInCapitalMember 2024-09-01 2024-11-30 0001071840 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-01 2024-11-30 0001071840 us-gaap:RetainedEarningsMember 2024-09-01 2024-11-30 0001071840 2024-09-01 2024-11-30 0001071840 us-gaap:CommonStockMember 2024-12-01 2025-02-28 0001071840 us-gaap:AdditionalPaidInCapitalMember 2024-12-01 2025-02-28 0001071840 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-01 2025-02-28 0001071840 us-gaap:RetainedEarningsMember 2024-12-01 2025-02-28 0001071840 2024-12-01 2025-02-28 0001071840 us-gaap:CommonStockMember 2025-03-01 2025-05-31 0001071840 us-gaap:AdditionalPaidInCapitalMember 2025-03-01 2025-05-31 0001071840 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-01 2025-05-31 0001071840 us-gaap:RetainedEarningsMember 2025-03-01 2025-05-31 0001071840 us-gaap:CommonStockMember 2026-05-31 0001071840 us-gaap:AdditionalPaidInCapitalMember 2026-05-31 0001071840 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-05-31 0001071840 us-gaap:RetainedEarningsMember 2026-05-31 0001071840 us-gaap:CommonStockMember 2025-05-31 0001071840 us-gaap:AdditionalPaidInCapitalMember 2025-05-31 0001071840 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-05-31 0001071840 us-gaap:RetainedEarningsMember 2025-05-31 0001071840 2025-05-31 0001071840 wndw:StockOptionsMember 2026-03-01 2026-05-31 0001071840 wndw:StockOptionsMember 2025-03-01 2025-05-31 0001071840 wndw:StockOptionsMember 2025-09-01 2026-05-31 0001071840 wndw:StockOptionsMember 2024-09-01 2025-05-31 0001071840 wndw:WarrantsMember 2026-03-01 2026-05-31 0001071840 wndw:WarrantsMember 2025-03-01 2025-05-31 0001071840 wndw:WarrantsMember 2025-09-01 2026-05-31 0001071840 wndw:WarrantsMember 2024-09-01 2025-05-31 0001071840 us-gaap:OfficeEquipmentMember 2026-05-31 0001071840 us-gaap:OfficeEquipmentMember 2025-08-31 0001071840 us-gaap:EquipmentMember 2026-05-31 0001071840 us-gaap:EquipmentMember 2025-08-31 0001071840 wndw:SeriesTMember 2026-05-31 0001071840 wndw:SeriesTMember 2025-08-31 0001071840 wndw:SeriesTMember 2025-09-01 2026-05-31 0001071840 wndw:SeriesUMember 2026-05-31 0001071840 wndw:SeriesUMember 2025-08-31 0001071840 wndw:SeriesUMember 2025-09-01 2026-05-31 0001071840 wndw:SeriesUOSMember 2026-05-31 0001071840 wndw:SeriesUOSMember 2025-08-31 0001071840 wndw:SeriesUOSMember 2025-09-01 2026-05-31 0001071840 us-gaap:StockOptionMember 2026-05-31 0001071840 us-gaap:StockOptionMember 2025-09-01 2026-05-31 0001071840 wndw:ExercisePriceOneMember 2026-05-31 0001071840 wndw:ExercisePriceOneMember 2025-09-01 2026-05-31 0001071840 wndw:ExercisePriceTwoMember 2026-05-31 0001071840 wndw:ExercisePriceTwoMember 2025-09-01 2026-05-31 0001071840 wndw:ExercisePriceThreeMember 2026-05-31 0001071840 wndw:ExercisePriceThreeMember 2025-09-01 2026-05-31 0001071840 wndw:ExercisePriceFourMember 2026-05-31 0001071840 wndw:ExercisePriceFourMember 2025-09-01 2026-05-31 0001071840 wndw:ExercisePriceFiveMember 2026-05-31 0001071840 wndw:ExercisePriceFiveMember 2025-09-01 2026-05-31 0001071840 wndw:ExercisePriceSixMember 2026-05-31 0001071840 wndw:ExercisePriceSixMember 2025-09-01 2026-05-31 0001071840 wndw:ExercisePriceSevenMember 2026-05-31 0001071840 wndw:ExercisePriceSevenMember 2025-09-01 2026-05-31 0001071840 wndw:SierchioLawLLPMember 2026-05-31 0001071840 wndw:SierchioLawLLPMember 2025-09-01 2026-05-31 0001071840 wndw:SierchioLawLLPMember 2025-08-31 0001071840 wndw:SierchioLawLLPMember 2025-06-01 2025-08-31 iso4217:USD shares iso4217:USD shares false 2026 Q3 --08-31 0001071840

10-Q true 2026-05-31 false 333-127953 SOLARWINDOW TECHNOLOGIES, INC. NV 59-3509694 9375 E. Shea Blvd. Suite 107-B Scottsdale AZ 85260 (800) 213-0689 Yes Yes Non-accelerated Filer true false false 65779045

4789312

6555642

4216

30687

46608

15836

4840136

6602165

60724

43089

4900860

6645254

193987

114309

112378 79866

306365

194175

306365

194175

0.10

1000000

0.001

300000000

65779045

65779

87475862

-82947146

-81090562

4594495

6451079

4900860

6645254

552995

385865

1470643

1339508

174013

167643

493500

478158

727008

553508

1964143

1817666

-727008

-553508

-1964143

-1817666

30602

13215

107560

96237

30602

13215

107560

96237

-696406

-540293

-1856583

-1721429

-5426 -30440

-696406

-545719

-1856583

-1751869

3559

-1110

-696406

-549278

-1856583

-1750759

-0.01

-0.03

-0.00

-0.01

-0.03

65779045

53198399

65779045

53198399

65779045

65779

87475862

-81090562

6451079

-570758

65779045

65779

87475862

-81661320

5880321

-589420

65779045

65779

87475862

-82250740

5290901

-696406

65779045

65779

87475862

-82947146

4594495

53198399

53198

83538904

-76702

-78833284

4682116

51563

2301

-552063

53198399

53198

83590467

-74401

-79385347

4183917

51562

2368

-654087

53198399

53198

83642029

-72033

-80039434

3583760

-3559

-545179

53198399

53198

83642029

-75592

-80585153

3034482

-1856583 -1721429 -30440

13715

5096

103125

-26471

25061

30772

-593444

79677

86978

32512

-15398

-1734980

-1003685

3000000

31350

8091

-31350

2991909

-1766330

1988224

6555642

1249446

4789312

3237670

NOTE 1 – Organization Organization SolarWindow Technologies, Inc. was incorporated in the State of Nevada on May 5, 1998 (the “Company”). SolarWindow® technology harvests light energy from the sun and from artificial light sources using a transparent and ultra-lightweight coating of organic photovoltaic (“OPV”) solar cells applied to glass and plastics, thereby generating electricity. The Company’s ticker symbol is WNDW. Liquidity The Company has not generated any revenue since inception and has sustained recurring losses and negative cash flows from operations since inception. We expect to incur losses as we continue to develop and further refine and promote our technologies and potential product applications. As of May 31, 2026, the Company had $4,789,312 of cash on hand, and working capital of $4,533,771. The Company believes that it currently has sufficient cash to meet its funding requirements over the next twelve months following the issuance of this Quarterly Report on Form 10-Q. However, the Company has experienced and continues to experience negative cash flows from operations, as well as an ongoing requirement for additional capital investment. The Company expects that it will need to raise additional capital to commercialize its electricity generating coatings and application methodology. The Company expects to seek to obtain that funding through financial or strategic investors. There can be no assurance as to the availability of such financings nor is it possible to determine at this time the terms and conditions upon which such financing and capital might be available.

4789312

4533771

<p id="xdx_801_eus-gaap--BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_zEhZkl4dhwgc" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">NOTE 2 – Interim Statement Presentation Basis of Presentation and Use of Estimates The accompanying unaudited interim consolidated financial statements of the Company as of May 31, 2026, and for the three and nine months ended May 31, 2026 and 2025 have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) for quarterly reports on Form 10-Q and do not include all of the information and note disclosures required by U.S. generally accepted accounting principles (“U.S. GAAP”) for complete financial statements. These Consolidated Financial Statements should therefore be read in conjunction with the Consolidated Financial Statements and Notes thereto for the fiscal year ended August 31, 2025, included in our Annual Report on Form 10-K filed with the SEC on November 13, 2025. The accompanying unaudited interim consolidated financial statements have been prepared in accordance with U.S. GAAP, which requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the accounting period. Actual results may differ from those estimates. The accompanying unaudited interim consolidated financial statements have been prepared on the same basis as the audited financial statements and include all adjustments (including normal recurring adjustments) that are, in the opinion of management, necessary for a fair presentation of the Company’s consolidated financial position as of May 31, 2026, results of operations, stockholders’ equity and cash flows for the three and nine months ended May 31, 2026 and 2025. The Company did not record an income tax provision during the periods presented due to net taxable losses. The results of operations for any interim period are not necessarily indicative of the results of operations for the entire year. These consolidated financial statements presented are those of the Company. For the three and nine months ended May 31, 2025, the Company recognized $5,426 and $30,440, respectively, of loss from its wholly owned subsidiaries, SolarWindow Asia (USA) Corp., and SolarWindow Asia Co. Ltd., which entities have been dissolved as of the beginning of fiscal 2026. All significant intercompany balances and transactions have been eliminated. Information regarding the Company’s significant accounting policies is contained in Note 2, “Summary of significant accounting policies,” to the consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended August 31, 2025. Presented below and in the following notes is supplemental information that should be read in conjunction with “Notes to Condensed Consolidated Financial Statements” in the Annual Report. Fiscal quarter The Company’s quarterly periods end on November 30, February 28, May 31, and August 31. The Company’s third quarter in fiscal 2026 and 2025 ended on May 31, 2026 and 2025, respectively. Net Income (Loss) Per Share The computation of basic earnings per share (“EPS”) is based on the weighted average number of shares that were outstanding during the period, including shares of common stock that are issuable at the end of the reporting period. The computation of diluted EPS is based on the number of basic weighted-average shares outstanding plus the number of common shares that would be issued assuming the exercise of all potentially dilutive common shares outstanding using the treasury stock method. The computation of diluted net income per share does not assume conversion, exercise or contingent issuance of securities that would have an antidilutive effect on earnings per share. Therefore, when calculating EPS if the Company experienced a loss, there is no inclusion of dilutive securities as their inclusion in the EPS calculation is antidilutive. Furthermore, options and warrants will have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options or warrants (they are in the money). The shares listed below were not included in the computation of diluted losses per share because to do so would be antidilutive for the periods presented: <table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zbMcjsrBePd5" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interim Statement Presentation (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Schedule of computation of diluted losses per share</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; background-color: White"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center; background-color: White">Three Months Ended May 31,</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center; background-color: White">Nine Months Ended May 31,</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt; background-color: White"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center; background-color: White">2026</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center; background-color: White">2025</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center; background-color: White">2026</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center; background-color: White">2025</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 48%; text-align: left">Stock options</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260301__20260531__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zwhZ9SZvVoF9" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Antidilutive shares">5,206,000</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250301__20250531__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zeSw1BHMwfM8" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Antidilutive shares">5,433,000</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250901__20260531__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zHWWyhc8dNBj" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Antidilutive shares">5,206,000</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240901__20250531__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zkFjCSWljSbi" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Antidilutive shares">5,433,000</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Warrants</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260301__20260531__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--WarrantsMember_z0nIMSP0c5B8" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">29,247,313</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250301__20250531__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--WarrantsMember_znzoVuB0TtVg" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">16,666,667</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250901__20260531__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--WarrantsMember_z6bgGwozCFAh" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">29,247,313</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240901__20250531__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--WarrantsMember_zm9P99kwaI8l" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">16,666,667</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260301__20260531_zHS759Hy3gXl" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">34,453,313</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250301__20250531_zCyugMh8a9f4" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">22,099,667</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250901__20260531_zpCAXK6pGwf3" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">34,453,313</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240901__20250531_zJiBCu7teQK8" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">22,099,667</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td></tr> </table> Accounting Pronouncements We evaluate all Accounting Standards Updates (“ASUs”) issued by the Financial Accounting Standards Board for consideration of their applicability. ASUs not included in our disclosures were assessed and determined to be either not applicable or are not expected to have a material impact on our unaudited condensed financial statements. Recently Adopted Accounting Pronouncements In November 2023, the FASB issued Accounting Standards Update (“ASU”) No. 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures” (“ASU 2023-07”). ASU 2023-07 expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses. The standard is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, which means ASU 2023-07 is effective for our annual periods beginning September 1, 2024, and our interim periods beginning September 1, 2025, or our current fiscal year which began on September 1, 2025. The Company adopted the ASU 2023-07 and determined that its adoption did not have a material impact on the Company’s financial statements and related interim disclosures. Recently Issued Accounting Pronouncements In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses. This new guidance is designed to improve the disclosures about the types of expenses, including employee compensation, depreciation, and amortization, and costs incurred related to inventory and manufacturing activities. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027 on a prospective basis with optional retrospective application. Early adoption is permitted. The Company is currently assessing the impact of this guidance on its disclosures. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which enhances the annual income tax disclosures for the effective tax rate reconciliation and income taxes paid. ASU 2023-09 is effective for our annual reporting periods beginning September 1, 2026, with early adoption permitted. The Company is currently assessing the impact of this guidance on its disclosures.

Basis of Presentation and Use of Estimates The accompanying unaudited interim consolidated financial statements of the Company as of May 31, 2026, and for the three and nine months ended May 31, 2026 and 2025 have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) for quarterly reports on Form 10-Q and do not include all of the information and note disclosures required by U.S. generally accepted accounting principles (“U.S. GAAP”) for complete financial statements. These Consolidated Financial Statements should therefore be read in conjunction with the Consolidated Financial Statements and Notes thereto for the fiscal year ended August 31, 2025, included in our Annual Report on Form 10-K filed with the SEC on November 13, 2025. The accompanying unaudited interim consolidated financial statements have been prepared in accordance with U.S. GAAP, which requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the accounting period. Actual results may differ from those estimates. The accompanying unaudited interim consolidated financial statements have been prepared on the same basis as the audited financial statements and include all adjustments (including normal recurring adjustments) that are, in the opinion of management, necessary for a fair presentation of the Company’s consolidated financial position as of May 31, 2026, results of operations, stockholders’ equity and cash flows for the three and nine months ended May 31, 2026 and 2025. The Company did not record an income tax provision during the periods presented due to net taxable losses. The results of operations for any interim period are not necessarily indicative of the results of operations for the entire year. These consolidated financial statements presented are those of the Company. For the three and nine months ended May 31, 2025, the Company recognized $5,426 and $30,440, respectively, of loss from its wholly owned subsidiaries, SolarWindow Asia (USA) Corp., and SolarWindow Asia Co. Ltd., which entities have been dissolved as of the beginning of fiscal 2026. All significant intercompany balances and transactions have been eliminated. Information regarding the Company’s significant accounting policies is contained in Note 2, “Summary of significant accounting policies,” to the consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended August 31, 2025. Presented below and in the following notes is supplemental information that should be read in conjunction with “Notes to Condensed Consolidated Financial Statements” in the Annual Report.

-5426

-30440

Fiscal quarter The Company’s quarterly periods end on November 30, February 28, May 31, and August 31. The Company’s third quarter in fiscal 2026 and 2025 ended on May 31, 2026 and 2025, respectively.

Net Income (Loss) Per Share The computation of basic earnings per share (“EPS”) is based on the weighted average number of shares that were outstanding during the period, including shares of common stock that are issuable at the end of the reporting period. The computation of diluted EPS is based on the number of basic weighted-average shares outstanding plus the number of common shares that would be issued assuming the exercise of all potentially dilutive common shares outstanding using the treasury stock method. The computation of diluted net income per share does not assume conversion, exercise or contingent issuance of securities that would have an antidilutive effect on earnings per share. Therefore, when calculating EPS if the Company experienced a loss, there is no inclusion of dilutive securities as their inclusion in the EPS calculation is antidilutive. Furthermore, options and warrants will have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options or warrants (they are in the money). The shares listed below were not included in the computation of diluted losses per share because to do so would be antidilutive for the periods presented: <table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zbMcjsrBePd5" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interim Statement Presentation (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Schedule of computation of diluted losses per share</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; background-color: White"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center; background-color: White">Three Months Ended May 31,</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center; background-color: White">Nine Months Ended May 31,</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt; background-color: White"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center; background-color: White">2026</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center; background-color: White">2025</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center; background-color: White">2026</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center; background-color: White">2025</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 48%; text-align: left">Stock options</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260301__20260531__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zwhZ9SZvVoF9" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Antidilutive shares">5,206,000</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250301__20250531__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zeSw1BHMwfM8" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Antidilutive shares">5,433,000</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250901__20260531__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zHWWyhc8dNBj" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Antidilutive shares">5,206,000</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240901__20250531__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zkFjCSWljSbi" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Antidilutive shares">5,433,000</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Warrants</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260301__20260531__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--WarrantsMember_z0nIMSP0c5B8" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">29,247,313</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250301__20250531__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--WarrantsMember_znzoVuB0TtVg" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">16,666,667</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250901__20260531__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--WarrantsMember_z6bgGwozCFAh" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">29,247,313</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240901__20250531__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--WarrantsMember_zm9P99kwaI8l" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">16,666,667</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260301__20260531_zHS759Hy3gXl" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">34,453,313</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250301__20250531_zCyugMh8a9f4" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">22,099,667</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250901__20260531_zpCAXK6pGwf3" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">34,453,313</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240901__20250531_zJiBCu7teQK8" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">22,099,667</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td></tr> </table>

<table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zbMcjsrBePd5" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interim Statement Presentation (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Schedule of computation of diluted losses per share</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; background-color: White"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center; background-color: White">Three Months Ended May 31,</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center; background-color: White">Nine Months Ended May 31,</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt; background-color: White"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center; background-color: White">2026</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center; background-color: White">2025</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center; background-color: White">2026</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center; background-color: White">2025</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 48%; text-align: left">Stock options</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260301__20260531__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zwhZ9SZvVoF9" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Antidilutive shares">5,206,000</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250301__20250531__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zeSw1BHMwfM8" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Antidilutive shares">5,433,000</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250901__20260531__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zHWWyhc8dNBj" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Antidilutive shares">5,206,000</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240901__20250531__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zkFjCSWljSbi" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Antidilutive shares">5,433,000</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Warrants</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260301__20260531__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--WarrantsMember_z0nIMSP0c5B8" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">29,247,313</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250301__20250531__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--WarrantsMember_znzoVuB0TtVg" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">16,666,667</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250901__20260531__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--WarrantsMember_z6bgGwozCFAh" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">29,247,313</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240901__20250531__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--WarrantsMember_zm9P99kwaI8l" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">16,666,667</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260301__20260531_zHS759Hy3gXl" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">34,453,313</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250301__20250531_zCyugMh8a9f4" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">22,099,667</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250901__20260531_zpCAXK6pGwf3" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">34,453,313</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240901__20250531_zJiBCu7teQK8" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">22,099,667</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td></tr> </table>

5206000

5433000

5206000

5433000

29247313

16666667

29247313

16666667

34453313

22099667

34453313

22099667

Accounting Pronouncements We evaluate all Accounting Standards Updates (“ASUs”) issued by the Financial Accounting Standards Board for consideration of their applicability. ASUs not included in our disclosures were assessed and determined to be either not applicable or are not expected to have a material impact on our unaudited condensed financial statements. Recently Adopted Accounting Pronouncements In November 2023, the FASB issued Accounting Standards Update (“ASU”) No. 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures” (“ASU 2023-07”). ASU 2023-07 expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses. The standard is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, which means ASU 2023-07 is effective for our annual periods beginning September 1, 2024, and our interim periods beginning September 1, 2025, or our current fiscal year which began on September 1, 2025. The Company adopted the ASU 2023-07 and determined that its adoption did not have a material impact on the Company’s financial statements and related interim disclosures. Recently Issued Accounting Pronouncements In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses. This new guidance is designed to improve the disclosures about the types of expenses, including employee compensation, depreciation, and amortization, and costs incurred related to inventory and manufacturing activities. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027 on a prospective basis with optional retrospective application. Early adoption is permitted. The Company is currently assessing the impact of this guidance on its disclosures. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which enhances the annual income tax disclosures for the effective tax rate reconciliation and income taxes paid. ASU 2023-09 is effective for our annual reporting periods beginning September 1, 2026, with early adoption permitted. The Company is currently assessing the impact of this guidance on its disclosures.

NOTE 3 – Property and Equipment Property and equipment consists of the following: <table cellpadding="0" cellspacing="0" id="xdx_884_eus-gaap--PropertyPlantAndEquipmentTextBlock_zIAh7aUOrDt7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and Equipment (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="color: Black; text-align: justify"> Schedule of Property and equipment </td><td style="color: Black"> </td> <td style="color: Black; text-align: left"> </td><td style="color: Black; text-align: right"> </td><td style="white-space: nowrap; color: Black; text-align: left"> </td><td style="color: Black"> </td> <td style="color: Black; text-align: left"> </td><td style="color: Black; text-align: right"> </td><td style="white-space: nowrap; color: Black; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: justify"> </td><td style="color: Black; font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; color: Black; font-weight: bold; text-align: center">May 31,</td><td style="color: Black; font-weight: bold"> </td><td style="color: Black; font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; color: Black; font-weight: bold; text-align: center">August 31,</td><td style="color: Black; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: justify"> </td><td style="color: Black; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: Black; font-weight: bold; text-align: center">2026</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; color: Black; text-align: left"> </td><td style="color: Black; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: Black; font-weight: bold; text-align: center">2025</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; color: Black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; color: Black; text-align: justify">Computers, office equipment and software</td><td style="width: 1%; color: Black"> </td> <td style="width: 1%; color: Black; text-align: left">$</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20260531__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_z1SuFrxhCStk" style="width: 12%; color: Black; text-align: right" title="Total property and equipment">28,266</td><td style="white-space: nowrap; width: 1%; color: Black; text-align: left"> </td><td style="width: 1%; color: Black"> </td> <td style="width: 1%; color: Black; text-align: left">$</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_pp0p0_c20250831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zZQhU821OUh9" style="width: 12%; color: Black; text-align: right" title="Total property and equipment">25,525</td><td style="white-space: nowrap; width: 1%; color: Black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: Black; text-align: justify; padding-bottom: 1pt">R&D Equipment</td><td style="color: Black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: Black; text-align: left"> </td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20260531__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zv2mKhIXrvn2" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Total property and equipment">190,475</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; color: Black; text-align: left"> </td><td style="color: Black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: Black; text-align: left"> </td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_pp0p0_c20250831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_z0m254PnSWie" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Total property and equipment">161,866</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; color: Black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 20pt; color: Black; text-align: justify">Total property and equipment</td><td style="color: Black"> </td> <td style="color: Black; text-align: left"> </td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20260531_zvBVLqurSNPg" style="color: Black; text-align: right" title="Total property and equipment">218,741</td><td style="white-space: nowrap; color: Black; text-align: left"> </td><td style="color: Black"> </td> <td style="color: Black; text-align: left"> </td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_pp0p0_c20250831_zopAWioVvLel" style="color: Black; text-align: right" title="Total property and equipment">187,391</td><td style="white-space: nowrap; color: Black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: Black; text-align: justify; padding-bottom: 1pt">Accumulated depreciation</td><td style="color: Black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: Black; text-align: left"> </td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentOtherAccumulatedDepreciation_iNI_pp0p0_di_c20260531_zjolNc5AEZHc" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Accumulated depreciation">(158,017</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; color: Black; text-align: left">)</td><td style="color: Black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: Black; text-align: left"> </td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentOtherAccumulatedDepreciation_iNI_pp0p0_di_c20250831_zOru1JyBIUEl" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Accumulated depreciation">(144,302</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; color: Black; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: Black; text-align: justify; padding-bottom: 2.5pt">Property and equipment, net</td><td style="color: Black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: Black; text-align: left">$</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20260531_zI2vlEbS1l5d" style="border-bottom: Black 2.5pt double; color: Black; text-align: right" title="Property and equipment, net">60,724</td><td style="border-bottom: Black 2.5pt double; white-space: nowrap; color: Black; text-align: left"> </td><td style="color: Black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: Black; text-align: left">$</td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentNet_pp0p0_c20250831_zX0jmzNGReUl" style="border-bottom: Black 2.5pt double; color: Black; text-align: right" title="Property and equipment, net">43,089</td><td style="border-bottom: Black 2.5pt double; white-space: nowrap; color: Black; text-align: left"> </td></tr> </table> During the three months ended May 31, 2026 and 2025, the Company recognized straight-line depreciation expense of $4,887 and $1,950, respectively. During the nine months ended May 31, 2026 and 2025, the Company recognized straight-line depreciation expense of $13,715 and $5,096, respectively.

<table cellpadding="0" cellspacing="0" id="xdx_884_eus-gaap--PropertyPlantAndEquipmentTextBlock_zIAh7aUOrDt7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and Equipment (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="color: Black; text-align: justify"> Schedule of Property and equipment </td><td style="color: Black"> </td> <td style="color: Black; text-align: left"> </td><td style="color: Black; text-align: right"> </td><td style="white-space: nowrap; color: Black; text-align: left"> </td><td style="color: Black"> </td> <td style="color: Black; text-align: left"> </td><td style="color: Black; text-align: right"> </td><td style="white-space: nowrap; color: Black; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: justify"> </td><td style="color: Black; font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; color: Black; font-weight: bold; text-align: center">May 31,</td><td style="color: Black; font-weight: bold"> </td><td style="color: Black; font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; color: Black; font-weight: bold; text-align: center">August 31,</td><td style="color: Black; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: justify"> </td><td style="color: Black; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: Black; font-weight: bold; text-align: center">2026</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; color: Black; text-align: left"> </td><td style="color: Black; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; color: Black; font-weight: bold; text-align: center">2025</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; color: Black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; color: Black; text-align: justify">Computers, office equipment and software</td><td style="width: 1%; color: Black"> </td> <td style="width: 1%; color: Black; text-align: left">$</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20260531__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_z1SuFrxhCStk" style="width: 12%; color: Black; text-align: right" title="Total property and equipment">28,266</td><td style="white-space: nowrap; width: 1%; color: Black; text-align: left"> </td><td style="width: 1%; color: Black"> </td> <td style="width: 1%; color: Black; text-align: left">$</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_pp0p0_c20250831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zZQhU821OUh9" style="width: 12%; color: Black; text-align: right" title="Total property and equipment">25,525</td><td style="white-space: nowrap; width: 1%; color: Black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: Black; text-align: justify; padding-bottom: 1pt">R&D Equipment</td><td style="color: Black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: Black; text-align: left"> </td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20260531__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zv2mKhIXrvn2" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Total property and equipment">190,475</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; color: Black; text-align: left"> </td><td style="color: Black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: Black; text-align: left"> </td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_pp0p0_c20250831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_z0m254PnSWie" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Total property and equipment">161,866</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; color: Black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 20pt; color: Black; text-align: justify">Total property and equipment</td><td style="color: Black"> </td> <td style="color: Black; text-align: left"> </td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20260531_zvBVLqurSNPg" style="color: Black; text-align: right" title="Total property and equipment">218,741</td><td style="white-space: nowrap; color: Black; text-align: left"> </td><td style="color: Black"> </td> <td style="color: Black; text-align: left"> </td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_pp0p0_c20250831_zopAWioVvLel" style="color: Black; text-align: right" title="Total property and equipment">187,391</td><td style="white-space: nowrap; color: Black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: Black; text-align: justify; padding-bottom: 1pt">Accumulated depreciation</td><td style="color: Black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: Black; text-align: left"> </td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentOtherAccumulatedDepreciation_iNI_pp0p0_di_c20260531_zjolNc5AEZHc" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Accumulated depreciation">(158,017</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; color: Black; text-align: left">)</td><td style="color: Black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: Black; text-align: left"> </td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentOtherAccumulatedDepreciation_iNI_pp0p0_di_c20250831_zOru1JyBIUEl" style="border-bottom: Black 1pt solid; color: Black; text-align: right" title="Accumulated depreciation">(144,302</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; color: Black; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: Black; text-align: justify; padding-bottom: 2.5pt">Property and equipment, net</td><td style="color: Black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: Black; text-align: left">$</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20260531_zI2vlEbS1l5d" style="border-bottom: Black 2.5pt double; color: Black; text-align: right" title="Property and equipment, net">60,724</td><td style="border-bottom: Black 2.5pt double; white-space: nowrap; color: Black; text-align: left"> </td><td style="color: Black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: Black; text-align: left">$</td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentNet_pp0p0_c20250831_zX0jmzNGReUl" style="border-bottom: Black 2.5pt double; color: Black; text-align: right" title="Property and equipment, net">43,089</td><td style="border-bottom: Black 2.5pt double; white-space: nowrap; color: Black; text-align: left"> </td></tr> </table>

28266

25525

190475

161866

218741

187391

158017

144302

60724

43089

4887

1950

13715

5096

NOTE 4 – Common Stock and Warrants Common Stock At May 31, 2026, the Company had 300,000,000 authorized shares of common stock with a par value of $0.001 per share, and 65,779,045 shares of common stock outstanding. Warrants Each of the Company’s warrants outstanding entitles the holder to purchase one share of the Company’s common stock for each warrant share held. The Series T Warrants may be exercised on a cashless basis. A summary of the Company’s warrants outstanding and exercisable as of May 31, 2026 and August 31, 2025: <table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zPUkzm7uyoTc" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Common Stock and Warrants (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left">Schedule of warrants outstanding and exercisable</td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; color: Black; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: center">Shares of Common Stock Issuable from Warrants Outstanding as of</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; color: Black; padding-bottom: 1pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: center">Weighted Average </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; color: Black"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="white-space: nowrap; font-size: 10pt"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="white-space: nowrap; font-size: 10pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: center">Description</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">May 31, 2026</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; color: Black"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: center">August 31, 2025</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="padding-bottom: 1pt; font-size: 10pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: center">Exercise Price</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; color: Black"> </td> <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: center">Date of Issuance</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; color: Black"> </td> <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: center">Expiration</td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td colspan="2" style="white-space: nowrap; font-size: 10pt"> </td><td style="padding-bottom: 1pt; font-size: 10pt"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td colspan="2" style="white-space: nowrap; font-size: 10pt"> </td><td style="padding-bottom: 1pt; font-size: 10pt"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td colspan="2" style="white-space: nowrap; font-size: 10pt"> </td><td style="padding-bottom: 1pt; font-size: 10pt"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="white-space: nowrap; font-size: 10pt"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="white-space: nowrap; font-size: 10pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 29%; color: Black; text-align: left">Series T Warrants</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; color: Black; text-align: left"> </td><td id="xdx_98B_ecustom--SharesOfCommonStockIssuableFromWarrants_c20260531__us-gaap--StatementClassOfStockAxis__custom--SeriesTMember_z2ikdMFkmRZg" style="font: 10pt Times New Roman, Times, Serif; width: 10%; color: Black; text-align: right" title="Shares of common stock issuable from warrants outstanding">16,666,667</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; color: Black; text-align: left"> </td><td id="xdx_983_ecustom--SharesOfCommonStockIssuableFromWarrants_c20250831__us-gaap--StatementClassOfStockAxis__custom--SeriesTMember_zV76rNBzOUB4" style="font: 10pt Times New Roman, Times, Serif; width: 10%; color: Black; text-align: right" title="Shares of common stock issuable from warrants outstanding">16,666,667</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; color: Black; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20260531__us-gaap--StatementClassOfStockAxis__custom--SeriesTMember_zLqGvoN5YHUi" style="font: 10pt Times New Roman, Times, Serif; width: 10%; color: Black; text-align: right" title="Weighted average exercise price">1.70</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%; color: Black; text-align: right">November 26, 2018</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%; color: Black; text-align: right">November 26, 2030</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left">Series U Warrants</td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left"> </td><td id="xdx_983_ecustom--SharesOfCommonStockIssuableFromWarrants_iI_c20260531__us-gaap--StatementClassOfStockAxis__custom--SeriesUMember_zq2DBYHn9Jw3" style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: right" title="Shares of common stock issuable from warrants outstanding">4,516,130</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left"> </td><td id="xdx_989_ecustom--SharesOfCommonStockIssuableFromWarrants_iI_c20250831__us-gaap--StatementClassOfStockAxis__custom--SeriesUMember_z9f0G8hkWdx1" style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: right" title="Shares of common stock issuable from warrants outstanding">4,516,130</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20260531__us-gaap--StatementClassOfStockAxis__custom--SeriesUMember_zoL0ju9PSZ4e" style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: right" title="Weighted average exercise price">0.47</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: right">June 16, 2025</td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: right">June 16, 2028</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left; padding-bottom: 1pt">Series U-OS Warrants</td><td style="font: 10pt Times New Roman, Times, Serif; color: Black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left"> </td><td id="xdx_98F_ecustom--SharesOfCommonStockIssuableFromWarrants_iI_c20260531__us-gaap--StatementClassOfStockAxis__custom--SeriesUOSMember_zTxB2x0ZPLU3" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: Black; text-align: right" title="Shares of common stock issuable from warrants outstanding">8,064,516</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left"> </td><td id="xdx_985_ecustom--SharesOfCommonStockIssuableFromWarrants_iI_c20250831__us-gaap--StatementClassOfStockAxis__custom--SeriesUOSMember_z3cVcO9PZo17" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: Black; text-align: right" title="Shares of common stock issuable from warrants outstanding">8,064,516</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black; padding-bottom: 1pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20260531__us-gaap--StatementClassOfStockAxis__custom--SeriesUOSMember_zBtMaLaUnS7d" style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: right" title="Weighted average exercise price">0.47</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black; padding-bottom: 1pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: right; padding-bottom: 1pt">June 16, 2025</td><td style="font: 10pt Times New Roman, Times, Serif; color: Black; padding-bottom: 1pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: right; padding-bottom: 1pt">June 16, 2028</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; padding-bottom: 2.5pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; color: Black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left"> </td><td id="xdx_984_ecustom--SharesOfCommonStockIssuableFromWarrants_iI_c20260531_zKGkZBYGg0Si" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; color: Black; text-align: right" title="Shares of common stock issuable from warrants outstanding">29,247,313</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left"> </td><td id="xdx_988_ecustom--SharesOfCommonStockIssuableFromWarrants_iI_c20250831_z13GRLIJ7OU4" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; color: Black; text-align: right" title="Shares of common stock issuable from warrants outstanding">29,247,313</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="white-space: nowrap; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td></tr> </table>

300000000

0.001

65779045

<table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zPUkzm7uyoTc" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Common Stock and Warrants (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left">Schedule of warrants outstanding and exercisable</td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; color: Black; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: center">Shares of Common Stock Issuable from Warrants Outstanding as of</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; color: Black; padding-bottom: 1pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: center">Weighted Average </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; color: Black"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="white-space: nowrap; font-size: 10pt"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="white-space: nowrap; font-size: 10pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: center">Description</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">May 31, 2026</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; color: Black"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: center">August 31, 2025</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="padding-bottom: 1pt; font-size: 10pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: center">Exercise Price</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; color: Black"> </td> <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: center">Date of Issuance</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; color: Black"> </td> <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: center">Expiration</td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td colspan="2" style="white-space: nowrap; font-size: 10pt"> </td><td style="padding-bottom: 1pt; font-size: 10pt"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td colspan="2" style="white-space: nowrap; font-size: 10pt"> </td><td style="padding-bottom: 1pt; font-size: 10pt"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td colspan="2" style="white-space: nowrap; font-size: 10pt"> </td><td style="padding-bottom: 1pt; font-size: 10pt"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="white-space: nowrap; font-size: 10pt"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="white-space: nowrap; font-size: 10pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 29%; color: Black; text-align: left">Series T Warrants</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; color: Black; text-align: left"> </td><td id="xdx_98B_ecustom--SharesOfCommonStockIssuableFromWarrants_c20260531__us-gaap--StatementClassOfStockAxis__custom--SeriesTMember_z2ikdMFkmRZg" style="font: 10pt Times New Roman, Times, Serif; width: 10%; color: Black; text-align: right" title="Shares of common stock issuable from warrants outstanding">16,666,667</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; color: Black; text-align: left"> </td><td id="xdx_983_ecustom--SharesOfCommonStockIssuableFromWarrants_c20250831__us-gaap--StatementClassOfStockAxis__custom--SeriesTMember_zV76rNBzOUB4" style="font: 10pt Times New Roman, Times, Serif; width: 10%; color: Black; text-align: right" title="Shares of common stock issuable from warrants outstanding">16,666,667</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; color: Black; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20260531__us-gaap--StatementClassOfStockAxis__custom--SeriesTMember_zLqGvoN5YHUi" style="font: 10pt Times New Roman, Times, Serif; width: 10%; color: Black; text-align: right" title="Weighted average exercise price">1.70</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%; color: Black; text-align: right">November 26, 2018</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%; color: Black; text-align: right">November 26, 2030</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left">Series U Warrants</td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left"> </td><td id="xdx_983_ecustom--SharesOfCommonStockIssuableFromWarrants_iI_c20260531__us-gaap--StatementClassOfStockAxis__custom--SeriesUMember_zq2DBYHn9Jw3" style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: right" title="Shares of common stock issuable from warrants outstanding">4,516,130</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left"> </td><td id="xdx_989_ecustom--SharesOfCommonStockIssuableFromWarrants_iI_c20250831__us-gaap--StatementClassOfStockAxis__custom--SeriesUMember_z9f0G8hkWdx1" style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: right" title="Shares of common stock issuable from warrants outstanding">4,516,130</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20260531__us-gaap--StatementClassOfStockAxis__custom--SeriesUMember_zoL0ju9PSZ4e" style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: right" title="Weighted average exercise price">0.47</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: right">June 16, 2025</td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: right">June 16, 2028</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left; padding-bottom: 1pt">Series U-OS Warrants</td><td style="font: 10pt Times New Roman, Times, Serif; color: Black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left"> </td><td id="xdx_98F_ecustom--SharesOfCommonStockIssuableFromWarrants_iI_c20260531__us-gaap--StatementClassOfStockAxis__custom--SeriesUOSMember_zTxB2x0ZPLU3" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: Black; text-align: right" title="Shares of common stock issuable from warrants outstanding">8,064,516</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left"> </td><td id="xdx_985_ecustom--SharesOfCommonStockIssuableFromWarrants_iI_c20250831__us-gaap--StatementClassOfStockAxis__custom--SeriesUOSMember_z3cVcO9PZo17" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: Black; text-align: right" title="Shares of common stock issuable from warrants outstanding">8,064,516</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black; padding-bottom: 1pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20260531__us-gaap--StatementClassOfStockAxis__custom--SeriesUOSMember_zBtMaLaUnS7d" style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: right" title="Weighted average exercise price">0.47</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black; padding-bottom: 1pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: right; padding-bottom: 1pt">June 16, 2025</td><td style="font: 10pt Times New Roman, Times, Serif; color: Black; padding-bottom: 1pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: right; padding-bottom: 1pt">June 16, 2028</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; padding-bottom: 2.5pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; color: Black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left"> </td><td id="xdx_984_ecustom--SharesOfCommonStockIssuableFromWarrants_iI_c20260531_zKGkZBYGg0Si" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; color: Black; text-align: right" title="Shares of common stock issuable from warrants outstanding">29,247,313</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left"> </td><td id="xdx_988_ecustom--SharesOfCommonStockIssuableFromWarrants_iI_c20250831_z13GRLIJ7OU4" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; color: Black; text-align: right" title="Shares of common stock issuable from warrants outstanding">29,247,313</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="white-space: nowrap; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td></tr> </table>

16666667 16666667

1.70

2018-11-26 2030-11-26 4516130 4516130

0.47

2025-06-16 2028-06-16 8064516 8064516

0.47

2025-06-16 2028-06-16 29247313 29247313

<p id="xdx_80F_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zI5OnrI5lDg" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">NOTE 5 - Stock Options The Company measures share-based compensation cost on the grant date, based on the fair value of the award, and recognizes the expense on a straight-line basis over the requisite service period for awards expected to vest. The Company estimates the grant date fair value of stock options using a Black-Scholes valuation model. No stock options were granted during the nine months ended May 31, 2026 and 2025. A summary of the Company’s stock option activity for the nine months ended May 31, 2026 and related information follows: <table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_z6ooh9SzNRBd" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stock Options (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Schedule of stock option activity</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; white-space: nowrap; font-size: 10pt; font-weight: bold">Number of Shares Subject to Option Grants</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; white-space: nowrap; font-size: 10pt; font-weight: bold">Weighted Average Exercise Price ($)</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: center; white-space: nowrap; font-size: 10pt; font-weight: bold">Weighted Average Remaining Contractual Term</td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; white-space: nowrap; font-size: 10pt; font-weight: bold">Aggregate Intrinsic Value ($)</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 49%">Outstanding at May 31, 2026</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20260531__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zDI1VhMJtjwl" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Number of shares subject to option grants, outstanding">5,206,000</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20260531__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zTZiyY1Fejdk" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Weighted average exercise price, outstanding balance">2.37</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250901__20260531__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z7si0D7KTcId" title="Weighted average remaining contractual term (years), outstanding">2.79 years</td> <td style="width: 1%"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_pp0p0_d0_c20260531__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zHcOsasc3Ca9" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Aggregate intrinsic value, outstanding">-</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Exercisable at May 31, 2026</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20260531__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zcmcA8CxSWPj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares subject to option grants, exercisable">5,206,000</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iI_c20260531__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zhgrauy2lse3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercisable">2.37</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20250901__20260531__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zJT1wh55gI2d" title="Weighted average remaining contractual term (years), exercisable">2.79 years</td> <td> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iI_pp0p0_d0_c20260531__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zHL87PwJrC5i" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate intrinsic value, Exercisable">-</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td></tr> </table> The aggregate intrinsic value in the table above represents the total pretax intrinsic value for all “in-the-money” options (i.e. the difference between the Company’s closing stock price on the last trading day of the period covered by this report and the exercise price, multiplied by the number of shares) that would have been received by the option holders had all in-the-money option holders exercised their vested options on May 31, 2026. The intrinsic value of the option changes based upon the fair market value of the Company’s common stock. Since the closing stock price was $0.28 on May 29, 2026 and <span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumbers_iI_do_c20260531__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zMWwabURNUh5" title="Stock options outstanding">no outstanding options have an exercise price below $<span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_c20260531__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zH5ZiFYiyr04" title="Option exercise price">0.28 per share, as of May 31, 2026, thus there is <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_do_c20260531__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zpTUcekJSyoa" title="Aggregate intrinsic value, outstanding">no intrinsic value to the Company’s vested stock options. The following table sets forth the share-based compensation cost resulting from stock option grants, including those previously granted and vesting over time, that were recorded in the Company’s Statements of Operations for the three and nine months ended May 31, 2026 and 2025: <table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_zPjcGm9zCmq6" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stock Options (Details 1)"> <tr style="vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; background-color: White">Schedule of share-based compensation</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left; background-color: White"> </td><td id="xdx_499_20260301__20260531_zGVFzx0m7pvl" style="font-size: 10pt; text-align: right; background-color: White"> </td><td style="white-space: nowrap; font-size: 10pt; text-align: left; background-color: White"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left; background-color: White"> </td><td id="xdx_493_20250301__20250531_ztYJpl6Ue8d9" style="font-size: 10pt; text-align: right; background-color: White"> </td><td style="white-space: nowrap; font-size: 10pt; text-align: left; background-color: White"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left; background-color: White"> </td><td id="xdx_499_20250901__20260531_zy2s2H0Pt226" style="font-size: 10pt; text-align: right; background-color: White"> </td><td style="white-space: nowrap; font-size: 10pt; text-align: left; background-color: White"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left; background-color: White"> </td><td id="xdx_493_20240901__20250531_zgcW17TQooHe" style="font-size: 10pt; text-align: right; background-color: White"> </td><td style="white-space: nowrap; font-size: 10pt; text-align: left; background-color: White"> </td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; background-color: White"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center; background-color: White">Three Months Ended May 31,</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center; background-color: White">Nine Months Ended May 31,</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt; background-color: White"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center; background-color: White">2026</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center; background-color: White">2025</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center; background-color: White">2026</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center; background-color: White">2025</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td></tr> <tr id="xdx_408_ecustom--StockCompensationExpenseAbstract_iB" style="vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; background-color: White">Stock compensation expense:</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left; background-color: White"> </td><td style="font-size: 10pt; text-align: right; background-color: White"> </td><td style="white-space: nowrap; font-size: 10pt; text-align: left; background-color: White"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left; background-color: White"> </td><td style="font-size: 10pt; text-align: right; background-color: White"> </td><td style="white-space: nowrap; font-size: 10pt; text-align: left; background-color: White"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left; background-color: White"> </td><td style="font-size: 10pt; text-align: right; background-color: White"> </td><td style="white-space: nowrap; font-size: 10pt; text-align: left; background-color: White"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left; background-color: White"> </td><td style="font-size: 10pt; text-align: right; background-color: White"> </td><td style="white-space: nowrap; font-size: 10pt; text-align: left; background-color: White"> </td></tr> <tr id="xdx_407_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_maSBCzwgv_ztabq87Yfu3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 48%; text-align: left">Selling, general and administrative</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">103,125</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; text-align: left"> </td></tr> </table> The following table summarizes information about stock options outstanding and exercisable at May 31, 2026: <table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_z3QtcEk9XRl7" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stock Options (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: center"> Schedule of Stock Options Outstanding </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock options outstanding, number of shares subject to outstanding options"> </td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: center" title="Stock options outstanding, weighted average exercise price"> </td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock options exercisable, number of shares subject to options exercise"> </td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: center" title="Stock options exercisable, weighted average exercise price"> </td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; padding-bottom: 1pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td colspan="9" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">Stock Options Outstanding </td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td colspan="9" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">Stock Options Exercisable </td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt">Range of Exercise Prices</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">Number of Shares Subject to Outstanding Options</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average Contractual Life (years)</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average Exercise Price ($)</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">Number of Shares Subject To Options Exercise</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average Remaining Contractual Life (Years)</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average Exercise Price ($)</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 16%; color: Black; text-align: center">0.33</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zPKygEPxeCVh" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Stock options outstanding, number of shares subject to outstanding options">1,250,000</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: center"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250901__20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_z85DB0pYUc6e" title="Stock options outstanding, weighted average contractural life (years)">2.86</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; color: Black; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zOIbenplkOUi" style="font: 10pt Times New Roman, Times, Serif; width: 11%; color: Black; text-align: center" title="Stock options outstanding, weighted average exercise price">0.33</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zReCba6V7rWb" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Stock options exercisable, number of shares subject to options exercise">1,250,000</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: center"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20250901__20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_z6e2ZmTNPlaf" title="Stock options exercisable, weighted average remaining contractural life (Years)">2.86</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; color: Black; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zVQUT6yq03of" style="font: 10pt Times New Roman, Times, Serif; width: 11%; color: Black; text-align: center" title="Stock options exercisable, weighted average exercise price">0.33</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; color: Black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: center">2.32</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zkEFB4U3WTBd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock options outstanding, number of shares subject to outstanding options">153,000</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250901__20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zna1nqORjTn3" title="Stock options outstanding, weighted average contractural life (years)">3.37</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zYNu74yyLqz2" style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: center" title="Stock options outstanding, weighted average exercise price">2.32</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_z7hZw797VA55" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock options exercisable, number of shares subject to options exercise">153,000</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20250901__20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zxprBjreTa17" title="Stock options exercisable, weighted average remaining contractural life (Years)">3.37</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zm29nBwGmrp" style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: center" title="Stock options exercisable, weighted average exercise price">2.32</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: center">2.60</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_zivFhEUbAfM2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock options outstanding, number of shares subject to outstanding options">2,500,000</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250901__20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_zVg3l6r0Tju7" title="Stock options outstanding, weighted average contractural life (years)">2.69</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_zS3fNRQgIAM1" style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: center" title="Stock options outstanding, weighted average exercise price">2.60</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_zGPq1q1YCbP1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock options exercisable, number of shares subject to options exercise">2,500,000</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20250901__20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_zc6jmS9R57kj" title="Stock options exercisable, weighted average remaining contractural life (Years)">2.69</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_zhPaFaSseWT5" style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: center" title="Stock options exercisable, weighted average exercise price">2.60</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: center">3.42</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceFourMember_zSe1vsdYVny3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock options outstanding, number of shares subject to outstanding options">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250901__20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceFourMember_zqqYIAmQKMKl" title="Stock options outstanding, weighted average contractural life (years)">0.39</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceFourMember_zkfAKnw8HzI6" style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: center" title="Stock options outstanding, weighted average exercise price">3.42</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceFourMember_zsbU1TrZACa5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock options exercisable, number of shares subject to options exercise">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20250901__20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceFourMember_zgKONzSwmjuk" title="Stock options exercisable, weighted average remaining contractural life (Years)">0.39</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceFourMember_zbeOF7elO31c" style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: center" title="Stock options exercisable, weighted average exercise price">3.42</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: center">3.54</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceFiveMember_zqSl1Is8DZf2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock options outstanding, number of shares subject to outstanding options">1,033,000</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250901__20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceFiveMember_zAdG40T1c0mg" title="Stock options outstanding, weighted average contractural life (years)">2.69</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceFiveMember_zpO9Bdn6ckZ4" style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: center" title="Stock options outstanding, weighted average exercise price">3.54</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceFiveMember_z9jhwevX2Sx9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock options exercisable, number of shares subject to options exercise">1,033,000</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20250901__20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceFiveMember_z3OTXqtYzJQ" title="Stock options exercisable, weighted average remaining contractural life (Years)">2.69</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceFiveMember_zAGxEisAMHla" style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: center" title="Stock options exercisable, weighted average exercise price">3.54</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: center">4.87</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceSixMember_zq9sBNuBEZcf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock options outstanding, number of shares subject to outstanding options">110,000</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250901__20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceSixMember_zkerhhUXQyGl" title="Stock options outstanding, weighted average contractural life (years)">2.47</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceSixMember_z6VnMV20VRE3" style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: center" title="Stock options outstanding, weighted average exercise price">4.87</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceSixMember_zYyLeWGbp1Mk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock options exercisable, number of shares subject to options exercise">110,000</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20250901__20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceSixMember_zMHvr4XpwwC2" title="Stock options exercisable, weighted average remaining contractural life (Years)">2.47</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceSixMember_zzhFikDghsN" style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: center" title="Stock options exercisable, weighted average exercise price">4.87</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt">6.21</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceSevenMember_zneOpOEwCr76" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock options outstanding, number of shares subject to outstanding options">110,000</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250901__20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceSevenMember_z5ncN2ub2fga" title="Stock options outstanding, weighted average contractural life (years)">5.42</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceSevenMember_zJ4MxRhF3AE3" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Stock options outstanding, weighted average exercise price">6.21</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceSevenMember_zlHH9pVL0rf9" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock options exercisable, number of shares subject to options exercise">110,000</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20250901__20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceSevenMember_zvJJbKlkOjtk" title="Stock options exercisable, weighted average remaining contractural life (Years)">5.42</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceSevenMember_zgDN40qhwp26" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Stock options exercisable, weighted average exercise price">6.21</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 2.5pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20260531_zNb8oSt6N39l" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock options outstanding, number of shares subject to outstanding options">5,206,000</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250901__20260531_z8m7oHpaUHNb" title="Stock options outstanding, weighted average contractural life (years)">2.79</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20260531_znNfFGuPm4i9" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Stock options outstanding, weighted average exercise price">2.37</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20260531_zfbPeuZVvgwj" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock options exercisable, number of shares subject to options exercise">5,206,000</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20250901__20260531_zjCZfsooQ0Hf" title="Stock options exercisable, weighted average remaining contractural life (Years)">2.79</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iI_c20260531_zm8LFZRSg73k" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Stock options exercisable, weighted average exercise price">2.37</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td></tr> </table>

<table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_z6ooh9SzNRBd" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stock Options (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Schedule of stock option activity</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; white-space: nowrap; font-size: 10pt; font-weight: bold">Number of Shares Subject to Option Grants</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; white-space: nowrap; font-size: 10pt; font-weight: bold">Weighted Average Exercise Price ($)</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: center; white-space: nowrap; font-size: 10pt; font-weight: bold">Weighted Average Remaining Contractual Term</td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; white-space: nowrap; font-size: 10pt; font-weight: bold">Aggregate Intrinsic Value ($)</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 49%">Outstanding at May 31, 2026</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20260531__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zDI1VhMJtjwl" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Number of shares subject to option grants, outstanding">5,206,000</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20260531__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zTZiyY1Fejdk" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Weighted average exercise price, outstanding balance">2.37</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250901__20260531__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z7si0D7KTcId" title="Weighted average remaining contractual term (years), outstanding">2.79 years</td> <td style="width: 1%"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_pp0p0_d0_c20260531__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zHcOsasc3Ca9" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Aggregate intrinsic value, outstanding">-</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Exercisable at May 31, 2026</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20260531__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zcmcA8CxSWPj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares subject to option grants, exercisable">5,206,000</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iI_c20260531__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zhgrauy2lse3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercisable">2.37</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20250901__20260531__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zJT1wh55gI2d" title="Weighted average remaining contractual term (years), exercisable">2.79 years</td> <td> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iI_pp0p0_d0_c20260531__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zHL87PwJrC5i" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate intrinsic value, Exercisable">-</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td></tr> </table>

5206000

2.37

P2Y9M14D

-0

5206000

2.37

P2Y9M14D

-0

0.28 0

0.28

<table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_zPjcGm9zCmq6" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stock Options (Details 1)"> <tr style="vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; background-color: White">Schedule of share-based compensation</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left; background-color: White"> </td><td id="xdx_499_20260301__20260531_zGVFzx0m7pvl" style="font-size: 10pt; text-align: right; background-color: White"> </td><td style="white-space: nowrap; font-size: 10pt; text-align: left; background-color: White"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left; background-color: White"> </td><td id="xdx_493_20250301__20250531_ztYJpl6Ue8d9" style="font-size: 10pt; text-align: right; background-color: White"> </td><td style="white-space: nowrap; font-size: 10pt; text-align: left; background-color: White"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left; background-color: White"> </td><td id="xdx_499_20250901__20260531_zy2s2H0Pt226" style="font-size: 10pt; text-align: right; background-color: White"> </td><td style="white-space: nowrap; font-size: 10pt; text-align: left; background-color: White"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left; background-color: White"> </td><td id="xdx_493_20240901__20250531_zgcW17TQooHe" style="font-size: 10pt; text-align: right; background-color: White"> </td><td style="white-space: nowrap; font-size: 10pt; text-align: left; background-color: White"> </td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; background-color: White"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center; background-color: White">Three Months Ended May 31,</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center; background-color: White">Nine Months Ended May 31,</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt; background-color: White"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center; background-color: White">2026</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center; background-color: White">2025</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center; background-color: White">2026</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center; background-color: White">2025</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td></tr> <tr id="xdx_408_ecustom--StockCompensationExpenseAbstract_iB" style="vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; background-color: White">Stock compensation expense:</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left; background-color: White"> </td><td style="font-size: 10pt; text-align: right; background-color: White"> </td><td style="white-space: nowrap; font-size: 10pt; text-align: left; background-color: White"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left; background-color: White"> </td><td style="font-size: 10pt; text-align: right; background-color: White"> </td><td style="white-space: nowrap; font-size: 10pt; text-align: left; background-color: White"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left; background-color: White"> </td><td style="font-size: 10pt; text-align: right; background-color: White"> </td><td style="white-space: nowrap; font-size: 10pt; text-align: left; background-color: White"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left; background-color: White"> </td><td style="font-size: 10pt; text-align: right; background-color: White"> </td><td style="white-space: nowrap; font-size: 10pt; text-align: left; background-color: White"> </td></tr> <tr id="xdx_407_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_maSBCzwgv_ztabq87Yfu3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 48%; text-align: left">Selling, general and administrative</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">103,125</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; text-align: left"> </td></tr> </table>

103125

<table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_z3QtcEk9XRl7" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stock Options (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: center"> Schedule of Stock Options Outstanding </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock options outstanding, number of shares subject to outstanding options"> </td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: center" title="Stock options outstanding, weighted average exercise price"> </td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock options exercisable, number of shares subject to options exercise"> </td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: center" title="Stock options exercisable, weighted average exercise price"> </td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; padding-bottom: 1pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td colspan="9" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">Stock Options Outstanding </td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td colspan="9" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">Stock Options Exercisable </td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt">Range of Exercise Prices</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">Number of Shares Subject to Outstanding Options</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average Contractual Life (years)</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average Exercise Price ($)</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">Number of Shares Subject To Options Exercise</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average Remaining Contractual Life (Years)</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average Exercise Price ($)</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 16%; color: Black; text-align: center">0.33</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zPKygEPxeCVh" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Stock options outstanding, number of shares subject to outstanding options">1,250,000</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: center"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250901__20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_z85DB0pYUc6e" title="Stock options outstanding, weighted average contractural life (years)">2.86</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; color: Black; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zOIbenplkOUi" style="font: 10pt Times New Roman, Times, Serif; width: 11%; color: Black; text-align: center" title="Stock options outstanding, weighted average exercise price">0.33</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zReCba6V7rWb" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Stock options exercisable, number of shares subject to options exercise">1,250,000</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: center"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20250901__20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_z6e2ZmTNPlaf" title="Stock options exercisable, weighted average remaining contractural life (Years)">2.86</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; color: Black; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zVQUT6yq03of" style="font: 10pt Times New Roman, Times, Serif; width: 11%; color: Black; text-align: center" title="Stock options exercisable, weighted average exercise price">0.33</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%; color: Black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: center">2.32</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zkEFB4U3WTBd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock options outstanding, number of shares subject to outstanding options">153,000</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250901__20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zna1nqORjTn3" title="Stock options outstanding, weighted average contractural life (years)">3.37</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zYNu74yyLqz2" style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: center" title="Stock options outstanding, weighted average exercise price">2.32</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_z7hZw797VA55" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock options exercisable, number of shares subject to options exercise">153,000</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20250901__20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zxprBjreTa17" title="Stock options exercisable, weighted average remaining contractural life (Years)">3.37</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zm29nBwGmrp" style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: center" title="Stock options exercisable, weighted average exercise price">2.32</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: center">2.60</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_zivFhEUbAfM2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock options outstanding, number of shares subject to outstanding options">2,500,000</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250901__20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_zVg3l6r0Tju7" title="Stock options outstanding, weighted average contractural life (years)">2.69</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_zS3fNRQgIAM1" style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: center" title="Stock options outstanding, weighted average exercise price">2.60</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_zGPq1q1YCbP1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock options exercisable, number of shares subject to options exercise">2,500,000</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20250901__20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_zc6jmS9R57kj" title="Stock options exercisable, weighted average remaining contractural life (Years)">2.69</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_zhPaFaSseWT5" style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: center" title="Stock options exercisable, weighted average exercise price">2.60</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: center">3.42</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceFourMember_zSe1vsdYVny3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock options outstanding, number of shares subject to outstanding options">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250901__20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceFourMember_zqqYIAmQKMKl" title="Stock options outstanding, weighted average contractural life (years)">0.39</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceFourMember_zkfAKnw8HzI6" style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: center" title="Stock options outstanding, weighted average exercise price">3.42</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceFourMember_zsbU1TrZACa5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock options exercisable, number of shares subject to options exercise">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20250901__20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceFourMember_zgKONzSwmjuk" title="Stock options exercisable, weighted average remaining contractural life (Years)">0.39</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceFourMember_zbeOF7elO31c" style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: center" title="Stock options exercisable, weighted average exercise price">3.42</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: center">3.54</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceFiveMember_zqSl1Is8DZf2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock options outstanding, number of shares subject to outstanding options">1,033,000</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250901__20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceFiveMember_zAdG40T1c0mg" title="Stock options outstanding, weighted average contractural life (years)">2.69</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceFiveMember_zpO9Bdn6ckZ4" style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: center" title="Stock options outstanding, weighted average exercise price">3.54</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceFiveMember_z9jhwevX2Sx9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock options exercisable, number of shares subject to options exercise">1,033,000</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20250901__20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceFiveMember_z3OTXqtYzJQ" title="Stock options exercisable, weighted average remaining contractural life (Years)">2.69</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceFiveMember_zAGxEisAMHla" style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: center" title="Stock options exercisable, weighted average exercise price">3.54</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: center">4.87</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceSixMember_zq9sBNuBEZcf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock options outstanding, number of shares subject to outstanding options">110,000</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250901__20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceSixMember_zkerhhUXQyGl" title="Stock options outstanding, weighted average contractural life (years)">2.47</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceSixMember_z6VnMV20VRE3" style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: center" title="Stock options outstanding, weighted average exercise price">4.87</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceSixMember_zYyLeWGbp1Mk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock options exercisable, number of shares subject to options exercise">110,000</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20250901__20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceSixMember_zMHvr4XpwwC2" title="Stock options exercisable, weighted average remaining contractural life (Years)">2.47</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; color: Black"> </td> <td style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceSixMember_zzhFikDghsN" style="font: 10pt Times New Roman, Times, Serif; color: Black; text-align: center" title="Stock options exercisable, weighted average exercise price">4.87</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; color: Black; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt">6.21</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceSevenMember_zneOpOEwCr76" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock options outstanding, number of shares subject to outstanding options">110,000</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250901__20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceSevenMember_z5ncN2ub2fga" title="Stock options outstanding, weighted average contractural life (years)">5.42</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceSevenMember_zJ4MxRhF3AE3" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Stock options outstanding, weighted average exercise price">6.21</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceSevenMember_zlHH9pVL0rf9" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock options exercisable, number of shares subject to options exercise">110,000</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20250901__20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceSevenMember_zvJJbKlkOjtk" title="Stock options exercisable, weighted average remaining contractural life (Years)">5.42</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iI_c20260531__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceSevenMember_zgDN40qhwp26" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Stock options exercisable, weighted average exercise price">6.21</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 2.5pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20260531_zNb8oSt6N39l" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock options outstanding, number of shares subject to outstanding options">5,206,000</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250901__20260531_z8m7oHpaUHNb" title="Stock options outstanding, weighted average contractural life (years)">2.79</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20260531_znNfFGuPm4i9" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Stock options outstanding, weighted average exercise price">2.37</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20260531_zfbPeuZVvgwj" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock options exercisable, number of shares subject to options exercise">5,206,000</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20250901__20260531_zjCZfsooQ0Hf" title="Stock options exercisable, weighted average remaining contractural life (Years)">2.79</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iI_c20260531_zm8LFZRSg73k" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Stock options exercisable, weighted average exercise price">2.37</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td></tr> </table>

1250000

P2Y10M9D

0.33

1250000

P2Y10M9D

0.33

153000

P3Y4M13D

2.32

153000

P3Y4M13D

2.32

2500000

P2Y8M8D

2.60

2500000

P2Y8M8D

2.60

50000

P0Y4M20D

3.42

50000

P0Y4M20D

3.42

1033000

P2Y8M8D

3.54

1033000

P2Y8M8D

3.54

110000

P2Y5M19D

4.87

110000

P2Y5M19D

4.87

110000

P5Y5M1D

6.21

110000

P5Y5M1D

6.21

5206000

P2Y9M14D

2.37

5206000

P2Y9M14D

2.37

NOTE 6 - Transactions with Related Persons A related party with respect to the Company is generally defined as any person (i) (and, if a natural person, inclusive of his or her immediate family) that holds 10% or more of the Company’s securities, (ii) that is part of the Company’s management, (iii) that directly or indirectly controls, is controlled by or is under common control with the Company, or (iv) who can significantly influence the financial and operating decisions of the Company. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties. Joseph Sierchio, one of the Company’s directors, has maintained his role as the Company’s general counsel since 2005. Currently, Mr. Sierchio, as principal of Sierchio Law, LLP, serves as the Company’s general counsel on an hourly basis at the rate of $750 per hour. Fees for legal services billed by Sierchio Law, LLP totaled approximately $60,625 and $72,393 for the three months ended May 31, 2026 and 2025, respectively, and $204,775 and $209,093 for the nine months ended May 31, 2026 and 2025, respectively. As of May 31, 2026, the Company recognized a related party payable to Sierchio Law, LLP of $63,125, including $60,625 related to legal services and $2,500 related to the quarterly board fee for the three months ended May 31, 2026. As of August 31, 2025, the Company recognized a related party payable to Sierchio Law, LLP of $54,625, including $52,125 related to legal services and $2,500 related to the quarterly board fee for the three months ended August 31, 2025. All related party transactions are recorded at the exchange amount established and agreed to between related parties and are in the normal course of business.

60625

72393

204775

209093

63125

60625

2500

54625

52125

2500

NOTE 7 – Subsequent Events Management has reviewed material events subsequent of the period ended May 31, 2026 and through the date of filing of financial statements in accordance with FASB ASC 855 “Subsequent Events”. In managements opinion, no material subsequent events have occurred as of the date of this quarterly report.